Spots Global Cancer Trial Database for Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Official Title: Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Study ID: NCT01918527
Conditions
Study Description
Brief Summary: The purpose of this study is to compare 3 cycles of neoadjuvant (preoperative) chemotherapy + operation with the standard treatment of locally advanced colon cancer, which is operation + 8 cycles of (adjuvant) chemotherapy. Patients receiving neoadjuvant chemotherapy may not need adjuvant chemotherapy after the operation and, if this is the case, they will be spared of 5 cycles of chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Aalborg University Hospital, Aalborg, , Denmark
Rigshospitalet, Copenhagen, , Denmark
Herlev Hospital, Herlev, , Denmark
Hilleroed Hospital, Hillerød, , Denmark
Roskilde Hospital, Roskilde, , Denmark
Sygehus Sønderjylland, Sønderborg, , Denmark
Vejle Hospital, Vejle, , Denmark
Haukeland University Hospital, Bergen, , Norway
Sahlgrenska University Hospital, Göteborg, , Sweden
Contact Details
Name: Anders Jakobsen, DMSc
Affiliation: Vejle Hospital, Vejle, Denmark
Role: STUDY_CHAIR
Name: Henrik Jensen, MD, PhD
Affiliation: Vejle Hospital, Vejle, Denmark
Role: PRINCIPAL_INVESTIGATOR
Name: Olav Dahl, MD
Affiliation: Haukeland University Hospital, Bergen, Norway
Role: PRINCIPAL_INVESTIGATOR
Name: Göran Carlsson, MD
Affiliation: Sahlgrenska University Hospital, Gothenburg, Sweden
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
